Literature DB >> 6271901

One functional copy of the long terminal repeat gene specifying the immediate-early polypeptide IE 110 suffices for a productive infection of human foetal lung cells by herpes simplex virus.

A J Davison, H S Marsden, N M Wilkie.   

Abstract

The HSV-1/HSV-2 intertypic recombinant Bx1 (28-1) is heterotypic for the repeat sequences flanking the long unique region of the genome (IRL and TRL) and expresses both the immediate-early polypeptide IE 110 of HSV-1 and its functionally equivalent polypeptide IE 118 of HSV-2. The genome structures of five subclones of this recombinant and the immediate-early polypeptides they induce have been analysed. Subclone 14 lacked most of the IRL sequence, including the region from which part of the mRNA for IE 110 is transcribed, and expressed only the HSV-2 IE 118. Subclone 22 lacked almost all of TTL including the gene for IE 118 and induced only the HSV-1 IE 110. Since both subclones produced viable progeny in HFL cells it follows that expression of only one copy of the equivalent genes in TRL and IRL, here coding for the distinguishable polypeptides IE 110 or IE 118, is sufficient for successive complete cycles of virus replication.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271901     DOI: 10.1099/0022-1317-55-1-179

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Host cell-specific growth advantage of pseudorabies virus with a deletion in the genome sequences encoding a structural glycoprotein.

Authors:  T C Mettenleiter; B Lomniczi; N Sugg; C Schreurs; T Ben-Porat
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Novel rearrangements of herpes simplex virus DNA sequences resulting from duplication of a sequence within the unique region of the L component.

Authors:  K L Pogue-Geile; G T Lee; P G Spear
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.

Authors:  H S Marsden; A Buckmaster; J W Palfreyman; R G Hope; A C Minson
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

4.  The 65,000-Mr DNA-binding and virion trans-inducing proteins of herpes simplex virus type 1.

Authors:  H S Marsden; M E Campbell; L Haarr; M C Frame; D S Parris; M Murphy; R G Hope; M T Muller; C M Preston
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  Mutants defective in herpes simplex virus type 2 ICP4: isolation and preliminary characterization.

Authors:  C A Smith; P A Schaffer
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  The alpha protein ICP0 does not appear to play a major role in the regulation of herpes simplex virus gene expression during infection in tissue culture.

Authors:  R M Sandri-Goldin; R E Sekulovich; K Leary
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

7.  Control of expression of the herpes simplex virus-induced deoxypyrimidine triphosphatase in cells infected with mutants of herpes simplex virus types 1 and 2 and intertypic recombinants.

Authors:  F Wohlrab; B K Garrett; B Francke
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

8.  A HSV-1 variant (1720) generates four equimolar isomers despite a 9200-bp deletion from TRL and sequences between 9200 np and 97,000 np in inverted orientation being covalently bound to sequences 94,000-126,372 np.

Authors:  J Harland; S M Brown
Journal:  Virus Genes       Date:  1992-08       Impact factor: 2.332

9.  Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase.

Authors:  M L Gallo; D H Jackwood; M Murphy; H S Marsden; D S Parris
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  The immediate-early mRNA that encodes the regulatory polypeptide Vmw 175 of herpes simplex virus type 1 is unspliced.

Authors:  F J Rixon; M E Campbell; J B Clements
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.